Sign in

CIK 0001478320 · Large accelerated filer

Adaptive Biotechnologies Corp

Sign in to watch
Ticker
ADPT
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
WA
Entity type
operating
EIN
270907024
Phone
206-659-0067
Business address
1165 EASTLAKE AVE E, SEATTLE, WA, 98109
Former names
Adaptive TCR Corp
  1. 4 Open-market sale Chief People Officer sold 2,000 shares at an average $47.68 ($95,351)
  2. 4 Open-market sale Director sold 6,000 shares at an average $47.69 ($286,135)
  3. 4 Open-market sale Director sold 2,000 shares at an average $47.69 ($95,381)
  4. 4 Open-market sale 10% owner sold 2,500,000 shares at $49.52 ($123,787,500)
  5. 4 Open-market sale 10% owner sold 2,500,000 shares at $49.52 ($123,787,500)
  6. 4 Open-market sale Chief Financial Officer sold 30,000 shares at an average $49.16 ($1,474,705)
  7. 8-K Event Other events
  8. 4 Open-market sale Chief Medical Officer sold 6,250 shares at an average $50.63 ($316,449)
  9. 10-Q Report Quarterly Report
  10. 8-K Event Results of operations
  11. 4 Open-market sale Chief Scientific Officer sold 33,300 shares at an average $50.70 ($1,688,247)
  12. 4 Open-market sale Chief Business Development Off sold 6,772 shares at an average $45.58 ($308,642)
  13. 4 Open-market sale SVP and General Counsel sold 2,880 shares at an average $49.78 ($143,360)
  14. 4 Open-market sale Chief Business Development Off sold 417 shares at $51.25 ($21,371)
  15. 4 Open-market sale Chief Scientific Officer sold 11,100 shares at $51.79 ($574,869)
  16. 8-K Event Executive or director change
  17. 4 Open-market sale Chief Scientific Officer sold 22,200 shares at an average $51.86 ($1,151,338)
  18. 4 Open-market sale Director sold 2,000 shares at $51.51 ($103,020)
  19. 4 Open-market sale Chief People Officer sold 2,000 shares at $51.51 ($103,020)
  20. 4 Open-market sale Director sold 50,000 shares at an average $52.35 ($2,617,550)

Page 30 of 42 · 837 filings